CNS Pharma（CNSP.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他77.95%
机构投资者11.95%
对冲基金9.29%
个人与内部人士0.81%

主要股东

主要股东最新
股东
Ikarian Capital, LLC	9.29%	13.58 万	3.65%	+9.00 万	2026/06/30
ADAR1 Capital Management, LLC	4.79%	7.00 万	--	+7.00 万	2026/06/30
Stonepine Capital Management LLC	4.17%	6.10 万	3.55%	+1.22 万	2026/03/31
Ikarian Capital, LLC	3.14%	4.58 万	4.11%	+0	2026/03/31
Stonepine Capital Management LLC	2.84%	4.16 万	4.67%	-1.94 万	2026/06/30
Armistice Capital LLC	2.06%	3.02 万	2.71%	+0	2025/09/30
Armistice Capital LLC	2.06%	3.02 万	1.65%	+0	2025/09/30
Vanguard Capital Management, LLC	1.18%	1.72 万	--	+1.72 万	2026/06/30
Vanguard Capital Management, LLC	1.18%	1.72 万	--	+1.72 万	2026/06/30
Boothbay Fund Management, LLC	0.93%	1.35 万	1.21%	+0	2026/03/31
Boothbay Fund Management, LLC	0.93%	1.35 万	0.74%	+0	2026/06/30
Faith CharlesIndependent Chairman of Board	0.49%	7,100.00	0.49%	+7,100.00	2026/05/18
Faith CharlesIndependent Chairman of Board	0.49%	7,100.00	0.49%	+7,100.00	2026/05/18
Rami LevinPresident, CEO & Director	0.33%	4,750.00	--	+4,750.00	2026/08/14
Michal FisherIndependent Director	0.14%	2,000.00	--	+2,000.00	2026/05/18
UBS Asset Management AG	0.10%	1,461.00	0.01%	+732.00	2026/06/30
UBS Asset Management AG	0.10%	1,461.00	0.01%	+732.00	2026/06/30
Tower Research Capital Europe Limited	0.05%	799.00	0.11%	-511.00	2026/06/30
Tower Research Capital Europe Limited	0.05%	799.00	0.11%	-511.00	2026/06/30
Barclays Bank Plc	<0.01%	19.00	--	+19.00	2026/06/30